ThermoGenesis Holdings, Inc.

Form Type: 8-K

Filing Date: 2025-01-06

Corporate Action: Liquidation

Type: New

Accession Number: 000143774925000500

Comments: On December 31, 2024, the Board of Directors of ThermoGenesis Holdings, Inc. unanimously approved the closure of the Company’s Indian subsidiary, TotipotentRx Cell Therapy Private Limited, effective immediately. The decision was made due to minimal activities currently being conducted at the Indian subsidiary and noted that this closure will not affect the Company’s key business operations. The approval is documented in Exhibit 10.1 attached to the filing.

Document Link: View Document